(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ACE L B I O

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ACE L B I O

ST13

US500000079090693

Class

3, 5, 42

Filing

79090693

Registration

4072512

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

05/09/2023

Trademark type

Combined

Nice classes

3, 5, 42

Filing date

11/03/2010

Registration date

12/20/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/01/2022

Last transaction

07/01/2022

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

CN

Examiner

AYALA, LOURDES

Law office

L60

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the wording "ACELBIO" in stylized font.

Holders and representatives

Holders

Ancelbio (Chongqing) Biotechnology Co., Ltd.
TIANJIN ACELBIO CO., LTD

Representatives

TIANJIN ACELBIO CO., LTD

Technical classification

Nice Classes

Class 3Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Cosmetics; essential oils; perfumed extracts for tissues and perfumes; medicated soap; hair shampoos; cosmetic preparations for skin care; skin whitening creams; cosmetic preparations for slimming purposes; cosmetic sunscreen preparations; antiperspirants; non-medicated toiletries

Class 5

Opium alkaloid preparations for medical purposes; biological preparations for the treatment of cancercardiovascular disease and cranial nerve diseases; chemical preparations for pharmaceutical or medical purposesfor cancercardiovascular disease and cranial nerve diseases; ferments for pharmaceutical purposes; dietetic food adapted for medical purposes; medicinal herbs; hormones for medical purposes; Radio-isotope markers for therapeutic or diagnostic use; Biological tissue cultures for medical and veterinary use; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plants; Organ therapy preparations for pharmaceutical or medical purposesfor cancercardiovascular disease and cranial nerve diseases; pharmaceutical preparations for the treatment of cancercardiovascular disease and cranial nerve diseases; pharmaceutical preparations for skin care; vitamin preparations

Class 42

Biological research; bacteriological research; chemical analysis; chemistry research; chemistry servicesthe production of Small molecule drugsthe production of plant extracts and the production of active element of plant; cosmetics research; material testing; Quality control for others; Research and development of new products for others; Technical project studies in the field of medical supplies and healthcare products development; consultation in the field of environmental protectiondetection of plant species conservation advice; Technical consultancy in relation to research services relating to foods and dietary supplements

Publications

History of USPTO decisions and trademark events.

42 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

05/09/2023

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

04/19/2023

INPC

INVALIDATION PROCESSED

04/18/2023

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

03/01/2023

C71T

CANCELLED SECTION 71

07/01/2022

CHLD

CHANGE OF OWNER RECEIVED FROM IB

12/31/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/10/2021

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

12/20/2020

RNWL

INTERNATIONAL REGISTRATION RENEWED

11/19/2020

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

05/31/2017

71AG

REGISTERED-SEC.71 ACCEPTED

05/31/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/29/2017

ES71

TEAS SECTION 71 RECEIVED

01/11/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/11/2017

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

01/31/2013

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

06/25/2012

FICS

FINAL DISPOSITION NOTICE SENT TO IB

06/04/2012

FIMP

FINAL DISPOSITION PROCESSED

06/04/2012

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/20/2012

GPNX

NOTIFICATION PROCESSED BY IB

02/11/2012

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

01/13/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

12/20/2011

PUBO

PUBLISHED FOR OPPOSITION

10/04/2011

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/14/2011

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/14/2011

NPUB

NOTICE OF PUBLICATION

09/14/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

08/29/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/29/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/25/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/25/2011

ALIE

ASSIGNED TO LIE

08/18/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/11/2011

RFNT

REFUSAL PROCESSED BY IB

03/05/2011

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/16/2011

RFRR

REFUSAL PROCESSED BY MPU

02/16/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/16/2011

CNRT

NON-FINAL ACTION WRITTEN

02/15/2011

DOCK

ASSIGNED TO EXAMINER

02/14/2011

MAFR

APPLICATION FILING RECEIPT MAILED

01/08/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/04/2011

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

01/03/2011

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/30/2010

Continuous trademark protection

Get notified about every new filing that threatens ACE L B I O or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.